105 related articles for article (PubMed ID: 28400239)
21. Estrogen receptor ligands. II. Discovery of benzoxathiins as potent, selective estrogen receptor alpha modulators.
Kim S; Wu JY; Birzin ET; Frisch K; Chan W; Pai LY; Yang YT; Mosley RT; Fitzgerald PM; Sharma N; Dahllund J; Thorsell AG; DiNinno F; Rohrer SP; Schaeffer JM; Hammond ML
J Med Chem; 2004 Apr; 47(9):2171-5. PubMed ID: 15084115
[TBL] [Abstract][Full Text] [Related]
22. Hit-to-Lead Optimization of Mouse Trace Amine Associated Receptor 1 (mTAAR1) Agonists with a Diphenylmethane-Scaffold: Design, Synthesis, and Biological Study.
Chiellini G; Nesi G; Sestito S; Chiarugi S; Runfola M; Espinoza S; Sabatini M; Bellusci L; Laurino A; Cichero E; Gainetdinov RR; Fossa P; Raimondi L; Zucchi R; Rapposelli S
J Med Chem; 2016 Nov; 59(21):9825-9836. PubMed ID: 27731647
[TBL] [Abstract][Full Text] [Related]
23. Synthesis of GN8 derivatives and evaluation of their antiprion activity in TSE-infected cells.
Kimura T; Hosokawa-Muto J; Kamatari YO; Kuwata K
Bioorg Med Chem Lett; 2011 Mar; 21(5):1502-7. PubMed ID: 21277202
[TBL] [Abstract][Full Text] [Related]
24. Selective estrogen receptor modulators with conformationally restricted side chains. Synthesis and structure-activity relationship of ERalpha-selective tetrahydroisoquinoline ligands.
Renaud J; Bischoff SF; Buhl T; Floersheim P; Fournier B; Geiser M; Halleux C; Kallen J; Keller H; Ramage P
J Med Chem; 2005 Jan; 48(2):364-79. PubMed ID: 15658851
[TBL] [Abstract][Full Text] [Related]
25. Synthesis, binding and structure-affinity studies of new ligands for the microsomal anti-estrogen binding site (AEBS).
Poirot M; De Medina P; Delarue F; Perie JJ; Klaebe A; Faye JC
Bioorg Med Chem; 2000 Aug; 8(8):2007-16. PubMed ID: 11003145
[TBL] [Abstract][Full Text] [Related]
26. Diphenylpentane skeleton as a multi-template for steroid skeleton-recognizing receptors/enzymes.
Hosoda S; Matsuda D; Tomoda H; Hashimoto Y
Mini Rev Med Chem; 2009 May; 9(5):572-80. PubMed ID: 19456287
[TBL] [Abstract][Full Text] [Related]
27. [Towards bisphenols without hormonal effects].
Balaguer P; Delfosse V; Grimaldi M; Bourguet W
Med Sci (Paris); 2013 Jan; 29(1):14-7. PubMed ID: 23351685
[No Abstract] [Full Text] [Related]
28. Synthesis, biochemical properties and molecular modelling studies of organometallic specific estrogen receptor modulators (SERMs), the ferrocifens and hydroxyferrocifens: evidence for an antiproliferative effect of hydroxyferrocifens on both hormone-dependent and hormone-independent breast cancer cell lines.
Top S; Vessières A; Leclercq G; Quivy J; Tang J; Vaissermann J; Huché M; Jaouen G
Chemistry; 2003 Nov; 9(21):5223-36. PubMed ID: 14613131
[TBL] [Abstract][Full Text] [Related]
29. Antiestrogens and selective estrogen receptor modulators as multifunctional medicines. 2. Clinical considerations and new agents.
Jordan VC
J Med Chem; 2003 Mar; 46(7):1081-111. PubMed ID: 12646017
[No Abstract] [Full Text] [Related]
30. Recent advances in the synthesis of raloxifene: a selective estrogen receptor modulator.
Dadiboyena S
Eur J Med Chem; 2012 May; 51():17-34. PubMed ID: 22405286
[TBL] [Abstract][Full Text] [Related]
31. Estrogen receptor ligands. Part 8: Dihydrobenzoxathiin SERAMs with heteroatom-substituted side chains.
Blizzard TA; DiNinno F; Morgan JD; Wu JY; Chen HY; Kim S; Chan W; Birzin ET; Yang YT; Pai LY; Zhang Z; Hayes EC; DaSilva CA; Tang W; Rohrer SP; Schaeffer JM; Hammond ML
Bioorg Med Chem Lett; 2004 Aug; 14(15):3865-8. PubMed ID: 15225686
[TBL] [Abstract][Full Text] [Related]
32. Tetrahydroisoquinolines as subtype selective estrogen agonists/antagonists.
Chesworth R; Zawistoski MP; Lefker BA; Cameron KO; Day RF; Mangano FM; Rosati RL; Colella S; Petersen DN; Brault A; Lu B; Pan LC; Perry P; Ng O; Castleberry TA; Owen TA; Brown TA; Thompson DD; DaSilva-Jardine P
Bioorg Med Chem Lett; 2004 Jun; 14(11):2729-33. PubMed ID: 15125923
[TBL] [Abstract][Full Text] [Related]
33. Discovery of novel quinoline-based estrogen receptor ligands using peptide interaction profiling.
Hoekstra WJ; Patel HS; Liang X; Blanc JB; Heyer DO; Willson TM; Iannone MA; Kadwell SH; Miller LA; Pearce KH; Simmons CA; Shearin J
J Med Chem; 2005 Mar; 48(6):2243-7. PubMed ID: 15771467
[TBL] [Abstract][Full Text] [Related]
34. Combinatorial chemistry in steroid receptor drug discovery.
Flygare JA; Sutherlin DP; Brown SD
Methods Mol Biol; 2001; 176():353-8. PubMed ID: 11554335
[No Abstract] [Full Text] [Related]
35. Regioselective synthesis of 1,3,5-triaryl-4-alkylpyrazoles: novel ligands for the estrogen receptor.
Huang YR; Katzenellenbogen JA
Org Lett; 2000 Sep; 2(18):2833-6. PubMed ID: 10964377
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and biological evaluation of 2,3,4-triarylbenzopyran derivatives as SERM and therapeutic agent for breast cancer.
Kumar S; Deshpande S; Chandra V; Kitchlu S; Dwivedi A; Nayak VL; Konwar R; Prabhakar YS; Sahu DP
Bioorg Med Chem; 2009 Oct; 17(19):6832-40. PubMed ID: 19740667
[TBL] [Abstract][Full Text] [Related]
37. Metallodrug Conjugates with Steroids and Selective Estrogen Receptor Modulators (SERM).
Biersack B; Schobert R
Curr Med Chem; 2009; 16(18):2324-37. PubMed ID: 19519393
[TBL] [Abstract][Full Text] [Related]
38. Comparison of estrogen receptor alpha and beta subtypes based on comparative molecular field analysis (CoMFA).
Xing L; Welsh WJ; Tong W; Perkins R; Sheehan DM
SAR QSAR Environ Res; 1999; 10(2-3):215-37. PubMed ID: 10491851
[TBL] [Abstract][Full Text] [Related]
39. Synthesis of 3-alkyl naphthalenes as novel estrogen receptor ligands.
Fang J; Akwabi-Ameyaw A; Britton JE; Katamreddy SR; Navas F; Miller AB; Williams SP; Gray DW; Orband-Miller LA; Shearin J; Heyer D
Bioorg Med Chem Lett; 2008 Sep; 18(18):5075-7. PubMed ID: 18722117
[TBL] [Abstract][Full Text] [Related]
40. Synthesis, pharmacological evaluation, and structure-activity relationships of benzopyran derivatives with potent SERM activity.
Amari G; Armani E; Ghirardi S; Delcanale M; Civelli M; Caruso PL; Galbiati E; Lipreri M; Rivara S; Lodola A; Mor M
Bioorg Med Chem; 2004 Jul; 12(14):3763-82. PubMed ID: 15210143
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
